|
|
|
|
University of California, San Diego, Department of Pharmacology,
Cancer Center, La Jolla, California 92093-0636 (C.P.S., R.H.T.), and
Departments of
Abdominal and Transplant Surgery (K.O.) and
Gastroenterology and Hepatology (M.P.M.), Medizinische Hochschule
Hannover, 30625 Hannover, Germany
Family 1 UDP-glucuronosyltransferases (UGTs) (UGT1A) are encoded by a
locus that predicts the existence of at least nine individual proteins.
The different proteins are generated by exon-sharing, which results in
the production of a family of proteins that contain identical,
245-amino acid, carboxyl-terminal domains and an amino-terminal region
of approximately 280 amino acids. The diversity of the UGT1A locus suggests the existence of complex
regulation, most likely designed to account for the variable and
specific glucuronidation requirements. However, the tissue-specific and
extrahepatic regulation of the complete UGT1A locus has
not been defined to date. In this study, quantitative duplex reverse
transcription-polymerase chain reaction was used to analyze UGT1A RNA
expression in 16 hepatic, four biliary, and two gastric human tissue
specimens. UGT1A3 and UGT1A6 were found to be expressed in the three
tissues, whereas UGT1A5 and UGT1A8 were not expressed. Hepatocellular
and biliary tissue expressed UGT1A1 and UGT1A4 but hepatocellular
tissue uniquely expressed UGT1A9, whereas biliary tissue expressed
UGT1A10. In contrast to hepatocellular tissue, gastric tissue expressed
UGT1A7 in addition to UGT1A10. The expression of UGT1A9 in hepatic
tissue, UGT1A7 in gastric tissue, and UGT1A10 in biliary and gastric
tissue provides evidence for the selective regulation of the
UGT1A locus in hepatic and extrahepatic tissues. The
newly identified UGT1A7 and UGT1A10 transcripts were cloned and found
to be 95.86% identical. Sequence analysis confirmed two proteins with
divergent amino termini of 285 residues and identical carboxyl termini
of 245 residues. This study provides evidence for hepatic and
extrahepatic regulation of the human UGT1A locus and
identifies two novel extrahepatic transcripts of the UGT1A family.
This article has been cited by other articles:
![]() |
S. T. Stern, M. N. Tallman, K. K. Miles, J. K. Ritter, and P. C. Smith Androgen Regulation of Renal Uridine Diphosphoglucuronosyltransferase 1A1 in Rats Drug Metab. Dispos., September 1, 2008; 36(9): 1737 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-X. Liu, Y. Liu, J.-W. Zhang, W. Li, H.-T. Liu, and L. Yang UDP-Glucuronosyltransferase 1A6 Is the Major Isozyme Responsible for Protocatechuic Aldehyde Glucuronidation in Human Liver Microsomes Drug Metab. Dispos., August 1, 2008; 36(8): 1562 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chen, R. W. Dellinger, D. Sun, T. E. Spratt, and P. Lazarus Glucuronidation of Tobacco-Specific Nitrosamines by UGT2B10 Drug Metab. Dispos., May 1, 2008; 36(5): 824 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nguyen, J. A. Bonzo, S. Chen, S. Chouinard, M. J. Kelner, G. Hardiman, A. Belanger, and R. H. Tukey Disruption of the Ugt1 Locus in Mice Resembles Human Crigler-Najjar Type I Disease J. Biol. Chem., March 21, 2008; 283(12): 7901 - 7911. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zielinska, C. F. Lichti, S. Bratton, N. C. Mitchell, A. Gallus-Zawada, V.-H. Le, M. Finel, G. P. Miller, A. Radominska-Pandya, and J. H. Moran Glucuronidation of Monohydroxylated Warfarin Metabolites by Human Liver Microsomes and Human Recombinant UDP-Glucuronosyltransferases J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 139 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Tong, H. Li, I. Goljer, O. McConnell, and A. Chandrasekaran In Vitro Glucuronidation of Thyroxine and Triiodothyronine by Liver Microsomes and Recombinant Human UDP-Glucuronosyltransferases Drug Metab. Dispos., December 1, 2007; 35(12): 2203 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Hong, D. Huo, H.-J. Kim, Q. Niu, D. L. Fackenthal, S. A. Cummings, E. M. John, D. W. West, A. S. Whittemore, S. Das, et al. UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms and Total Bilirubin Levels in an Ethnically Diverse Cohort of Women Drug Metab. Dispos., August 1, 2007; 35(8): 1254 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-F. Yueh and R. H. Tukey Nrf2-Keap1 Signaling Pathway Regulates Human UGT1A1 Expression in Vitro and in Transgenic UGT1 Mice J. Biol. Chem., March 23, 2007; 282(12): 8749 - 8758. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Buckley and C. D. Klaassen Tissue- and Gender-Specific mRNA Expression of UDP-Glucuronosyltransferases (UGTs) in Mice Drug Metab. Dispos., January 1, 2007; 35(1): 121 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Gardner-Stephen and P. I. Mackenzie Isolation of the UDP-Glucuronosyltransferase 1A3 and 1A4 Proximal Promoters and Characterization of Their Dependence on the Transcription Factor Hepatocyte Nuclear Factor 1{alpha} Drug Metab. Dispos., January 1, 2007; 35(1): 116 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Anderson, A. Hasan, H. Yin, I. Qadri, and L. C. Quattrochi Regulation of the CYP1A1 Gene by 2,3,7,8-Tetrachlorodibenzo-p-dioxin but Not by beta-Naphthoflavone or 3-Methylcholanthrene Is Altered in Hepatitis C Virus Replicon-Expressing Cells Mol. Pharmacol., September 1, 2006; 70(3): 1062 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yan, G. W. Caldwell, D. Gauthier, G. C. Leo, J. Mei, C. Y. Ho, W. J. Jones, J. A. Masucci, R. W. Tuman, R. A. Galemmo Jr., et al. N-GLUCURONIDATION OF THE PLATELET-DERIVED GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR 6,7-(DIMETHOXY-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)-(3-FLUORO-PHENYL)-AMINE BY HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., May 1, 2006; 34(5): 748 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Finel, X. Li, D. Gardner-Stephen, S. Bratton, P. I. Mackenzie, and A. Radominska-Pandya Human UDP-Glucuronosyltransferase 1A5: Identification, Expression, and Activity J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1143 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, D. Beaton, N. Nguyen, K. Senekeo-Effenberger, E. Brace-Sinnokrak, U. Argikar, R. P. Remmel, J. Trottier, O. Barbier, J. K. Ritter, et al. Tissue-specific, Inducible, and Hormonal Control of the Human UDP-Glucuronosyltransferase-1 (UGT1) Locus J. Biol. Chem., November 11, 2005; 280(45): 37547 - 37557. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Bauman, T. C. Goosen, M. Tugnait, V. Peterkin, S. I. Hurst, L. C. Menning, M. Milad, M. H. Court, and J. A. Williams UDP-GLUCURONOSYLTRANSFERASE 2B7 IS THE MAJOR ENZYME RESPONSIBLE FOR GEMCABENE GLUCURONIDATION IN HUMAN LIVER MICROSOMES Drug Metab. Dispos., September 1, 2005; 33(9): 1349 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tachibana, M. Tanaka, Y. Masubuchi, and T. Horie ACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMES Drug Metab. Dispos., June 1, 2005; 33(6): 803 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Lankisch, A. Vogel, S. Eilermann, A. Fiebeler, B. Krone, A. Barut, M. P. Manns, and C. P. Strassburg Identification and Characterization of a Functional TATA Box Polymorphism of the UDP Glucuronosyltransferase 1A7 Gene Mol. Pharmacol., May 1, 2005; 67(5): 1732 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kaji and T. Kume REGIOSELECTIVE GLUCURONIDATION OF DENOPAMINE: MARKED SPECIES DIFFERENCES AND IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ISOFORM Drug Metab. Dispos., March 1, 2005; 33(3): 403 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Carlini, N. J. Meropol, J. Bever, M. L. Andria, T. Hill, P. Gold, A. Rogatko, H. Wang, and R. L. Blanchard UGT1A7 and UGT1A9 Polymorphisms Predict Response and Toxicity in Colorectal Cancer Patients Treated with Capecitabine/Irinotecan Clin. Cancer Res., February 1, 2005; 11(3): 1226 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kaji and T. Kume CHARACTERIZATION OF AFLOQUALONE N-GLUCURONIDATION: SPECIES DIFFERENCES AND IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ISOFORM(S) Drug Metab. Dispos., January 1, 2005; 33(1): 60 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Webb, K. K. Miles, D. J. Auyeung, F. K. Kessler, and J. K. Ritter ANALYSIS OF SUBSTRATE SPECIFICITIES AND TISSUE EXPRESSION OF RAT UDP-GLUCURONOSYLTRANSFERASES UGT1A7 AND UGT1A8 Drug Metab. Dispos., January 1, 2005; 33(1): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Barbier, H. Girard, Y. Inoue, H. Duez, L. Villeneuve, A. Kamiya, J.-C. Fruchart, C. Guillemette, F. J. Gonzalez, and B. Staels Hepatic Expression of the UGT1A9 Gene Is Governed by Hepatocyte Nuclear Factor 4{alpha} Mol. Pharmacol., January 1, 2005; 67(1): 241 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Christian, M. Lang, P. Maurel, and F. Raffalli-Mathieu Interaction of Heterogeneous Nuclear Ribonucleoprotein A1 with Cytochrome P450 2A6 mRNA: Implications for Post-Transcriptional Regulation of the CYP2A6 Gene Mol. Pharmacol., June 1, 2004; 65(6): 1405 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Gregory, R. H. Lewinsky, D. A. Gardner-Stephen, and P. I. Mackenzie Coordinate Regulation of the Human UDP-Glucuronosyltransferase 1A8, 1A9, and 1A10 Genes by Hepatocyte Nuclear Factor 1{alpha} and the Caudal-Related Homeodomain Protein 2 Mol. Pharmacol., April 1, 2004; 65(4): 953 - 963. [Abstract] [Full Text] |
||||
![]() |
Y. Wang, N. Kato, Y. Hoshida, M. Otsuka, H. Taniguchi, M. Moriyama, S. Shiina, T. Kawabe, Y. M. Ito, and M. Omata UDP-Glucuronosyltransferase 1A7 Genetic Polymorphisms Are Associated with Hepatocellular Carcinoma in Japanese Patients with Hepatitis C Virus Infection Clin. Cancer Res., April 1, 2004; 10(7): 2441 - 2446. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gardner-Stephen, J.-M. Heydel, A. Goyal, Y. Lu, W. Xie, T. Lindblom, P. Mackenzie, and A. Radominska-Pandya HUMAN PXR VARIANTS AND THEIR DIFFERENTIAL EFFECTS ON THE REGULATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE GENE EXPRESSION Drug Metab. Dispos., March 1, 2004; 32(3): 340 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ohno, Y. Saito, N. Hanioka, H. Jinno, M. Saeki, M. Ando, S. Ozawa, and J.-i. Sawada INVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOL Drug Metab. Dispos., February 1, 2004; 32(2): 235 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wiener, D. R. Doerge, J.-L. Fang, P. Upadhyaya, and P. Lazarus CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4 Drug Metab. Dispos., January 1, 2004; 32(1): 72 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Soars, D. M. Petullo, J. A. Eckstein, S. C. Kasper, and S. A. Wrighton AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES Drug Metab. Dispos., January 1, 2004; 32(1): 140 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cummings, B. T. Ethell, L. Jardine, G. Boyd, J. S. Macpherson, B. Burchell, J. F. Smyth, and D. I. Jodrell Glucuronidation as a Mechanism of Intrinsic Drug Resistance in Human Colon Cancer: Reversal of Resistance by Food Additives Cancer Res., December 1, 2003; 63(23): 8443 - 8450. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Gregory, D. A. Gardner-Stephen, R. H. Lewinsky, K. N. Duncliffe, and P. I. Mackenzie Cloning and Characterization of the Human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 Gene Promoters: DIFFERENTIAL REGULATION THROUGH AN INITIATOR-LIKE REGION J. Biol. Chem., September 19, 2003; 278(38): 36107 - 36114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wilkening, F. Stahl, and A. Bader COMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIES Drug Metab. Dispos., August 1, 2003; 31(8): 1035 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jinno, M. Saeki, Y. Saito, T. Tanaka-Kagawa, N. Hanioka, K. Sai, N. Kaniwa, M. Ando, K. Shirao, H. Minami, et al. Functional Characterization of Human UDP-Glucuronosyltransferase 1A9 Variant, D256N, Found in Japanese Cancer Patients J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 688 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jinno, M. Saeki, T. Tanaka-Kagawa, N. Hanioka, Y. Saito, S. Ozawa, M. Ando, K. Shirao, H. Minami, A. Ohtsu, et al. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10 Drug Metab. Dispos., May 1, 2003; 31(5): 528 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Strudwick, L. M. Carastro, T. Stagg, and P. Lazarus Differential Transcription-Coupled Translational Inhibition of Human p53 Expression: A Potentially Important Mechanism of Regulating p53 Expression in Normal versus Tumor Tissue Mol. Cancer Res., April 1, 2003; 1(6): 463 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Watanabe, M. Nakajima, and T. Yokoi Troglitazone Glucuronidation in Human Liver and Intestine Microsomes: High Catalytic Activity of UGT1A8 and UGT1A10 Drug Metab. Dispos., December 1, 2002; 30(12): 1462 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elahi, Z. Zheng, J. Park, K. Eyring, T. McCaffrey, and P. Lazarus The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk Carcinogenesis, July 1, 2002; 23(7): 1229 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
C P Strassburg, A Vogel, S Kneip, R H Tukey, and M P Manns Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer Gut, June 1, 2002; 50(6): 851 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takenaga, M. Ishii, T. Kamei, and T. Yasumori Structure-Activity Relationship in O-Glucuronidation of Indolocarbazole Analogs Drug Metab. Dispos., May 1, 2002; 30(5): 494 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Kessler, M. R. Kessler, D. J. Auyeung, and J. K. Ritter Glucuronidation of Acetaminophen Catalyzed by Multiple Rat Phenol UDP-Glucuronosyltransferases Drug Metab. Dispos., March 1, 2002; 30(3): 324 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
C P Strassburg, A Strassburg, S Kneip, A Barut, R H Tukey, B Rodeck, and M P Manns Developmental aspects of human hepatic drug glucuronidation in young children and adults Gut, February 1, 2002; 50(2): 259 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strassburg, C. P. Strassburg, M. P. Manns, and R. H. Tukey Differential Gene Expression of NAD(P)H:Quinone Oxidoreductase and NRH:Quinone Oxidoreductase in Human Hepatocellular and Biliary Tissue Mol. Pharmacol., February 1, 2002; 61(2): 320 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zheng, J. Y. Park, C. Guillemette, S. P. Schantz, and P. Lazarus Tobacco Carcinogen-Detoxifying Enzyme UGT1A7 and Its Association With Orolaryngeal Cancer Risk J Natl Cancer Inst, September 19, 2001; 93(18): 1411 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Luukkanen, J. Mikkola, T. Forsman, P. Taavitsainen, J. Taskinen, and E. Elovaara Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue Drug Metab. Dispos., August 1, 2001; 29(8): 1096 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-F. Yueh, N. Nguyen, M. Famourzadeh, C. P. Strassburg, Y. Oda, F.P. Guengerich, and R. H. Tukey The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines Carcinogenesis, June 1, 2001; 22(6): 943 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Tukey and C. P. Strassburg Genetic Multiplicity of the Human UDP-Glucuronosyltransferases and Regulation in the Gastrointestinal Tract Mol. Pharmacol., March 1, 2001; 59(3): 405 - 414. [Abstract] [Full Text] |
||||
![]() |
Y. Ando, H. Saka, M. Ando, T. Sawa, K. Muro, H. Ueoka, A. Yokoyama, S. Saitoh, K. Shimokata, and Y. Hasegawa Polymorphisms of UDP-Glucuronosyltransferase Gene and Irinotecan Toxicity: A Pharmacogenetic Analysis Cancer Res., December 1, 2000; 60(24): 6921 - 6926. [Abstract] [Full Text] |
||||
![]() |
Q. Ren, S. E. Murphy, Z. Zheng, and P. Lazarus O-Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1- (3-Pyridyl)-1-Butanol (nnal) by Human Udp-Glucuronosyltransferases 2b7 and 1a9 Drug Metab. Dispos., November 1, 2000; 28(11): 1352 - 1360. [Abstract] [Full Text] |
||||
![]() |
P. J. Czernik, J. M. Little, G. W. Barone, J.-P. Raufman, and A. Radominska-Pandya Glucuronidation of Estrogens and Retinoic Acid and Expression of UDP-Glucuronosyltransferase 2B7 in Human Intestinal Mucosa Drug Metab. Dispos., October 1, 2000; 28(10): 1210 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Metz, D. J. Auyeung, F. K. Kessler, and J. K. Ritter Involvement of Hepatocyte Nuclear Factor 1 in the Regulation of the UDP-Glucuronosyltransferase 1A7 (UGT1A7) Gene in Rat Hepatocytes Mol. Pharmacol., August 1, 2000; 58(2): 319 - 327. [Abstract] [Full Text] |
||||
![]() |
Q. Li, G. Lamb, and R. H. Tukey Characterization of the UDP-Glucuronosyltransferase 1A Locus in Lagomorphs: Evidence for Duplication of the UGT1A6 Gene Mol. Pharmacol., July 1, 2000; 58(1): 89 - 97. [Abstract] [Full Text] |
||||
![]() |
C. Guillemette, R. C. Millikan, B. Newman, and D. E. Housman Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans Cancer Res., February 1, 2000; 60(4): 950 - 956. [Abstract] [Full Text] |
||||
![]() |
M. Ciotti, V. M. Lakshmi, N. Basu, B. B. Davis, I. S. Owens, and T. V. Zenser Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides Carcinogenesis, October 1, 1999; 20(10): 1963 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bernard, H. Goudonnet, Y. Artur, B. Desvergne, and W. Wahli Activation of the Mouse TATA-less and Human TATA-Containing UDP-Glucuronosyltransferase 1A1 Promoters by Hepatocyte Nuclear Factor 1 Mol. Pharmacol., September 1, 1999; 56(3): 526 - 536. [Abstract] [Full Text] |
||||
![]() |
C. P. Strassburg, N. Nguyen, M. P. Manns, and R. H. Tukey Polymorphic Expression of the UDP-Glucuronosyltransferase UGT1A Gene Locus in Human Gastric Epithelium Mol. Pharmacol., October 1, 1998; 54(4): 647 - 654. [Abstract] [Full Text] |
||||
![]() |
M. D. Green and T. R. Tephly Glucuronidation of Amine Substrates by Purified and Expressed UDP-Glucuronosyltransferase Proteins Drug Metab. Dispos., September 1, 1998; 26(9): 860 - 867. [Abstract] [Full Text] |
||||
![]() |
M. D. Green, C. D. King, B. Mojarrabi, P. I. Mackenzie, and T. R. Tephly Glucuronidation of Amines and Other Xenobiotics Catalyzed by Expressed Human UDP-Glucuronosyltransferase 1A3 Drug Metab. Dispos., June 1, 1998; 26(6): 507 - 512. [Abstract] [Full Text] |
||||
![]() |
C. P. Strassburg, M. P. Manns, and R. H. Tukey Expression of the UDP-glucuronosyltransferase 1A Locus in Human Colon. IDENTIFICATION AND CHARACTERIZATION OF THE NOVEL EXTRAHEPATIC UGT1A8 J. Biol. Chem., April 10, 1998; 273(15): 8719 - 8726. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Metz and J. K. Ritter Transcriptional Activation of the UDP-Glucuronosyltransferase 1A7 Gene in Rat Liver by Aryl Hydrocarbon Receptor Ligands and Oltipraz J. Biol. Chem., March 6, 1998; 273(10): 5607 - 5614. [Abstract] [Full Text] [PDF] |
||||